Sunday, February 01, 2026 | 10:52 AM ISTहिंदी में पढें
Tatva Chintan Pharma Chem Ltd
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011
03:32 PM, 29th Jan 2026
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ajay Patel